氨溴索辅佐阿奇霉素治疗肺炎支原体疗效评价探讨

目的:评价氨溴索辅佐阿奇霉素治疗支原体肺炎患儿的临床疗效。方法:选取我院2015年5月~2016年5月收治的67例支原体肺炎患儿,分为观察组和参照组,给予参照组患儿阿奇霉素治疗,给予观察组患儿氨溴索辅佐阿奇霉素治疗。结果:观察组患儿咳嗽、肺部罗音的开始缓解时间均较参照组患儿早(P均0.05);观察组临床治疗总有效率为94.1%,高于参照组患儿的72.7%(P0.05);观察组住院时间为(7.8±2.1)d,短于参照组患儿的(10.7±2.3)d(P0.05)。结论:应用氨溴索辅佐阿奇霉素治疗支原体肺炎,药效发挥迅速,效果确切,具有临床推广应用价值。

To Evaluate the Curative Effect of Azithromycin Assisted by Ambroxol in the Treatment of Mycoplasma Pneumonia

Objective: To evaluate the clinical efficacy of azithromycin assisted by ambroxol in the treatment of children with Mycoplasma pneumonia. Methods: 67 cases of children with mycoplasma pneumonia from May 2015 to May 2016 in our hospital were divided into the observation group and the reference group. Arranging the treatment of azithromycin to the reference group, while the treatment of Azithromycin assisted by ambroxol to the observation group. Results: The observation group with symptoms of cough, fever, and pulmonary rales, was remitted early in disease median response time comparing with the reference group (P<0.05). Its total effective rate in clinical treatment was 94.1%, which higher than the reference group with 72.7% (P<0.05). And the length of stay of the observation group was(7.8±2.1)d, which shorter than the reference group (10.7±2.3) d (P<0.05). Serious adverse reaction did not occur in children of these two groups (P>0.05). Conclusions: Applying azithromycin assisted by ambroxol of mycoplasma pneumonia for it can catch pesticide effect rapidly, effectively, and safely, which has the value of clinical application.